Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
G Ambrosini, P. Marsilio, Samantha Sartori(Icahn School of Medicine at Mount Sinai), A. Farris, Patrizia Vici(Istituti di Ricovero e Cura a Carattere Scientifico), G. F. Garusi, F. Calabresi, G Marenco, G. Fila, Francesco Di Costanzo, C. Bumma(Ospedale San Giovanni Antica Sede), F Bonanni(University of Rome Tor Vergata), G Bruscagnin, F Grignani(University of Perugia), Giorgio Bonciarelli, Mauro Brugia, Otello Daniele, Franco Buzzi(Goethe University Frankfurt), Ugo Di Folco, M Balli, Rosana Poggio, Vincenzo Adamo(University of Messina), Gaia Chiesa, Enrico Capodicasa, Vinicio Fosser(Fondazione IRCCS Istituto Nazionale dei Tumori), Luigi Gallo(National Academies of Sciences, Engineering, and Medicine), Carlo Maria Foggi, Antonio Falchi, Romano Demicheli, B Blasina, Antonio Jirillo, Frédéric Lacroix, Giuseppe Altavilla(Azienda Ospedaliera Universitaria Policlinico "G. Martino"), Paola Papaldo(Cancer Institute (WIA)), P Bertoncelli, D. Padalino, E Camilluzzi, Luigi Di Lauro, M. Natali, G. Cartei, A. Fornasiero, V. Secondo(Ente Ospedaliero Ospedali Galliera), E Ciambellotti, S D'aquino, G Moro, M López(Hospital Sant Joan de Déu Barcelona), D. De Maria, Angelo Gambi(Florence (Netherlands)), Mario V. Fiorentino, Giovanni Battista Speranza
Cited by 168
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
|Journal of Immunological Methods|1991|4.6k
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
|Cell|1992|1.3k
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer
|Journal of Clinical Oncology|1999|639